Estrella Immunopharma, Inc. (ESLA): debt financing — TradeUP Acquisition Corp. Extends Business Combination Deadline to March 19, 2023 with Estrella Biopharma Deposit

Estrella Immunopharma, Inc.

Estrella Biopharma deposited $45,511 into TradeUP's trust account to extend the business combination deadline from February 19 to March 19, 2023.
TradeUP issued an unsecured promissory note (Extension Note) to Estrella for the deposit amount, bearing no interest and payable upon business combination.
Estrella has the right to convert the Extension Note into shares of TradeUP common stock at $10.00 per share.
The extension is part of the Merger Agreement dated September 30, 2022, and allows monthly extensions up to July 19, 2023.
The Extension Note was issued under exemption from registration under Section 4(a)(2) of the Securities Act.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Estrella Immunopharma, Inc. incurred loan of $45,511 with Estrella Biopharma, Inc. at no interest maturing upon the consummation of the Company's business combination.

Instrument: loan
Principal: $45,511
Counterparty: Estrella Biopharma, Inc.
Rate: no interest
Maturity: upon the consummation of the Company's business combination
Event: incurrence

Exact text from the filing

Estrella has deposited a monthly extension payment of $45,511 to the trust account of the Company to extend the deadline for the Company to complete the business combination contemplated therein by March 19, 2023. Such deposit is evidenced by an unsecured promissory note in the principal amount of o $45,511issued by the Company to Estrella (the “Extension Note”).

View on SEC.gov

Browse all debt financings →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001575872-23-000296

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.